|
Showing 1 - 4 of
4 matches in All Departments
For the first time in history, there is now hope for treating
neurological disorders that had previously been considered
untreatable. The remarkable confluence of events that has heralded
this is the focus of Neurotherapeutics in the Era of Translational
Medicine. This anthology, written by many of the prominent
scientists and researchers in the field of biotechnology, recounts
the breathtaking advances that are revolutionizing treatment for
disorders such as amyotrophic lateral sclerosis , spinal muscular
atrophy, multiple sclerosis, Parkinson's disease, myasthenia
gravis, migraine, and glioblastoma. The "story behind the story" of
these translational efforts is told, with authors depicting the ups
and downs encountered on the path of their drug discovery and
development effort. In parallel with this path, advances in
identifying novel biomarkers and disease models are summarized, as
are contemporary issues focusing on clinical trial design,
bioethics, innovative funding strategies, and collaborations
between government and academia in an effort to facilitate
breakthrough treatments. The book is written by members of the
biotech and pharmaceutical ecosystem for those who belong to it and
aspire to become part of it.
This is a reproduction of a book published before 1923. This book
may have occasional imperfections such as missing or blurred pages,
poor pictures, errant marks, etc. that were either part of the
original artifact, or were introduced by the scanning process. We
believe this work is culturally important, and despite the
imperfections, have elected to bring it back into print as part of
our continuing commitment to the preservation of printed works
worldwide. We appreciate your understanding of the imperfections in
the preservation process, and hope you enjoy this valuable book.
|
|